ArticleSarcoma2018

Cost-Effectiveness of Olaratumab in Combination with Doxorubicin for Patients with Soft Tissue Sarcoma in the United States.

Santiago Zuluaga-Sanchez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.